Thursday, May 30, 2013

James G. Carlson Selected to Join Board of Directors

SAN ANTONIO - Thursday, May 30th 2013 [ME NewsWire]

(BUSINESS WIRE)-- The Board of Directors of the parent company of Kinetic Concepts, Inc. and LifeCell Corporation is pleased to announce that James G. Carlson has agreed with the parent company’s financial sponsors to join the Board of Directors.

Mr. Carlson has more than 30 years of experience in health insurance. He is the former chief executive officer of Amerigroup, a position he held from 2007 to 2012. Mr. Carlson also served as chairman of Amerigroup’s Board of Directors since 2008. From 2003 to 2007 he served as Amerigroup’s president and chief operating officer. From 2003 to 2012 Amerigroup grew revenues from $1.6 billion in 2003 to $9 billion in 2012, earning recognition as a Fortune 500 company. Mr. Carlson successfully guided the company to its December 2012 acquisition by WellPoint, Inc., the second largest health insurer in the nation, at a sale price of nearly $5 billion.

“Jim Carlson’s depth of leadership and governance experience will be a valuable addition to our Board,” said Buddy Gumina, Chairman of the Board of Directors and Partner and Global Co-Head of Healthcare for Apax Partners. “Throughout his distinguished career, Jim has demonstrated a great deal of business success and has also served as a strong advocate for employees and patients alike. We are thrilled Jim has agreed to join the Board of Directors and look forward to his contributions.”

Mr. Carlson serves on the boards of The National Kidney Foundation and Virginia Aquarium & Marine Science Center. Previously, he served on the boards of America’s Health Insurance Plans, the Business Roundtable and the Health Sector Advisory Council for the Fuqua School of Business at Duke University.

“Jim’s experience in delivering high quality patient care while reducing overall cost to patients as well as public and private payors will complement our strategic focus on the post-acute care setting. KCI and LifeCell are committed to delivering innovative solutions that speed healing, reduce complications and improve patient lives in a cost effective manner,” said Joe Woody, president & CEO, KCI and interim CEO, LifeCell.

"KCI's and LifeCell’s products are instrumental in helping clinicians achieve superior outcomes for their patients and I'm delighted to have the opportunity to help both companies extend their leadership positions in wound care and surgical solutions," said Carlson.

About KCI

Kinetic Concepts, Inc. is a leading global medical technology company devoted to understanding, developing and commercializing innovative, high-technology Transformational Healing solutions for customers and patients in more than 25 countries around the world. Headquartered in San Antonio, Texas, KCI is committed to advancing the science of healing and positively impacting patient care by developing customer-driven innovation to meet the evolving needs of healthcare professionals. Proprietary KCI negative pressure technologies have revolutionized the way in which caregivers treat a wide variety of wound types. The V.A.C.® Therapy System has been used on approximately 7 million wounds worldwide. Additional information about KCI and its products is available at

About LifeCell

LifeCell Corporation, based in Bridgewater, NJ, is a leader in regenerative medicine, develops and markets innovative tissue repair products for the reconstructive, orthopedic and urogynecologic biosurgery markets. LifeCell™ products include Strattice™ Reconstructive Tissue Matrix and AlloDerm® Regenerative Tissue Matrix for plastic, reconstructive, and general surgical applications; Cymetra® Regenerative Tissue Matrix, a particulate form of AlloDerm® Tissue Matrix suitable for injection; Repliform® Regenerative Tissue Matrix for urogynecologic surgical procedures; GraftJacket® and Conexa™ for orthopedic surgical procedures; and the SPY® Elite System for the visualization and evaluation of tissue perfusion. Additional information about LifeCell and its products is available at

Financial Sponsors

The parent company of Kinetic Concepts, Inc. and LifeCell Corporation is controlled indirectly by investment funds advised by Apax Partners, Canada Pension Plan Investment Board, and the Public Sector Pension Investment Board.


KCI Corporate Communications

Mike Barger, 210-255-6824

Nordson EFD Releases Engineered Fluid Dispensing Product Catalog Fifth Edition

EAST PROVIDENCE, R.I. - Wednesday, May 29th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Nordson EFD, a Nordson company (NASDAQ: NDSN), has recently released its Engineered Fluid Dispensing Product Catalog Fifth Edition. The 112-page catalog details information about markets and applications that use and benefit from Nordson EFD precision dispensing systems, the fluids dispensed and dispensing applications for each industry, and customer comments. It contains complete descriptions of each EFD product with specifications, features, benefits, photos, diagrams, and charts, along with a comprehensive list of dispensing accessories. Fluid volumes and conversions, a helpful viscosity reference chart, dispensing tip recommendations, and a detailed valve selection guide are also included. The catalog is available in English, Chinese, French, German, Italian, Japanese, Korean, Portuguese, and Spanish.

“Nordson EFD’s wide variety of products, and the numerous applications they can be used for, is impressive. Their product catalog makes it easy to select the right products and accessories for the applications we’re working on,” said Aaron Carreiro, assistant process technician, Nye Lubricants.

Nordson EFD’s precision dispensing systems make it simple to apply accurate, repeatable amounts of virtually any assembly fluid, including adhesives, epoxies, lubricants, threadlockers, paints, and grease. Products range from high-precision valves and dispensers for critical applications that require a high degree of process control to benchtop units for general-purpose dispensing.

Industries include:

    1K and 2K (two component) fluid packaging
    Consumer packaging and food processing
    Life sciences
    Mobile devices

Products include:

    Fluid dispensing systems
    Dispensing components
    Nordson EFD® Optimum® controllers
    Fluid reservoirs and regulators
    Cartridge retainer systems
    Precision dispense, diaphragm, and spray valves, valve controllers, and accessories
    PICO® dispensing systems which dispense as much as 500 cycles per second
    MicroCoat® lubrication system
    Dispensing robots
    2K systems

Product Catalog available at:

Photo of Product Catalog cover at:

For more information, visit Nordson EFD on the web at,, or, email at, or call +1 401.431.7000 or 800.556.3484.

About Nordson EFD

Nordson EFD designs and manufactures precision fluid dispensing systems for benchtop assembly processes and automated assembly lines. By enabling manufacturers to apply the same amount of adhesive, lubricant or other assembly fluid to every part, every time, EFD dispensing systems are helping companies in a wide variety of industries increase throughput, improve quality, and lower their production costs. Other fluid management capabilities include high-quality syringe barrels and cartridges for packaging one- and two-component materials, along with a wide variety of fittings, couplers and connectors for controlling fluid flow in medical, biopharmaceutical and industrial environments. The company is also a leading formulator of specialty solder pastes for dispensing and printing applications in the electronics industry.

About Nordson Corporation

Nordson Corporation (NASDAQ: NDSN) delivers precision technology solutions to help customers succeed worldwide. The company engineers, manufactures and markets differentiated products and systems used for dispensing adhesives, coatings, sealants, biomaterials and other materials, fluid management, test and inspection, UV curing and plasma surface treatment, all supported by application expertise and direct global sales and service. Nordson serves a wide variety of consumer non-durable, durable and technology end markets including packaging, nonwovens, electronics, medical, appliances, energy, transportation, construction, and general product assembly and finishing. Founded in 1954 and headquartered in Westlake, Ohio, the company has operations and support offices in more than 30 countries. Visit Nordson on the web at, or


Nordson EFD

Rhonda Mitchell


East Providence, RI USA

USA & Canada: 800-556-3484;



Dunstable, Bedfordshire, UK

0800 585733; +44 (0) 1582 666334


Shanghai, China

+86 (21) 3866 9006


Tokyo, Japan

+81 (03) 5762 2760


Singapore: +65 6796 9522


A R Marketing, Inc. (agency)

+1 858-451-8666

Wednesday, May 29, 2013

Powerwave Technologies’ Turnkey Wireless Network Infrastructure, Telecom Inventory and Capital Assets Acquired by Industrial Auctioneers to Be Sold in Series of Upcoming Online Auctions

SAN DIEGO & SANTA ANA, Calif - Wednesday, May 29th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Heritage Global Partners (“HGP”), and its parent company Counsel RB Capital (OTCQB: CRBN), in conjunction with Maynards Industries Ltd, New Mill Capital LLC, and The Branford Group, today announced that they will jointly manage a series of sales for the complete turnkey wireless network infrastructure and related capital assets of Powerwave Technologies Inc. (NASDAQ: PWAV) (“Powerwave”).

Powerwave designs, manufactures, and markets a comprehensive suite of wireless technologies and is a global supplier of end-to-end wireless solutions for wireless communications networks. Together, the companies acquired Powerwave’s assets following its Chapter 11 bankruptcy (Case #13-10134) at an original asset acquisition cost of approximately $100 million. A series of global online auctions will be hosted and managed by Heritage, complete details and event dates to follow at

“Together with our valued partners we will be conducting a series of sales of Powerwave’s state-of-the-industry wireless network and capital assets. The upcoming auctions include an unprecedented offering of capital assets and will be the year’s largest sale of Test and Measurement equipment, by far. We believe our combined global presence and familiarity with the marketplace, paired with our expert industry knowledge, will attract significant interest from worldwide buyers,” stated Ross Dove, Managing Partner of Heritage Global Partners.

“We are anticipating very strong demand from buyers worldwide as the upcoming sales represent a unique opportunity to acquire a wealth of high quality assets, including base station antennas, tower mounted amplifiers (TMA), filters, furnishings, tooling, wireless inventory and equipment, and much more. We look forward to working together to maximize the ultimate value of Powerwave’s assets,” stated Matthew DelGuidice, VP of Maynards US Operations.

Led by auction industry pioneers Ross and Kirk Dove, Heritage Global Partners is one of the leading worldwide asset advisory and auction services firms, assisting companies with buying and selling assets. HGP specializes in asset brokerage, inspection, and valuations, industrial equipment and real estate auctions, and much more.


Heritage Global Partners

David Barkoff, 650-649-0147


Jennifer Neuman, 212-835-8500

Crystal IS Wins Top Honor at the 2013 BlueTech Forum Water Technology Showcase

GREEN ISLAND, N.Y. - Wednesday, May 29th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Crystal IS today announced its win of the Disrupt-o-Meter™ Award at the 2013 BlueTech Forum in Amsterdam. Crystal IS was selected from a range of participants for the water sector award honoring innovative, industry-revolutionizing technology.

“We are thrilled to be recognized by this global forum composed of water industry leaders, market experts and our peers,” said Therese Jordan, SVP of Business Development at Crystal IS. “This honor signifies the global market’s confidence in our technology and its future impact.”

BlueTech Research monitors the global water market for companies with innovative and disruptive technologies and a strong go-to-market strategy. The Disrupt-o-Meter Award is given to the water technology company that has the highest potential to not only influence existing markets, but open up new markets because of its ability to be used in various applications.

Additionally, the award analyzes the company's business model and the quality of service provided with the technology. “BlueTech Research has long been tracking and analyzing the market potential for innovative and disruptive water technologies. We believe that the technology presented by Crystal IS represents one of the strongest opportunities in the technical space in the next 5 to 10 years, and are excited about the potential for LEDs in the market, particularly within the water space. UV LEDs represent one of the top five potentially disruptive water technologies, with the global UV water disinfection market worth $1.1Bn. UV LEDs have the potential to disrupt this market and access market share, and equally importantly, to open up new applications and markets previously inaccessible to conventional UV lamp technology,” stated Paul O’Callaghan, CEO of BlueTech Research.

Crystal IS reported record outputs of greater than 60mW for their UVC LEDs earlier this year. As part of this award, Crystal IS will have the opportunity to showcase their products in the 2013 WEFTEC Innovation Pavilion at the conference in Chicago, IL this October.


Crystal IS, Inc., an Asahi Kasei company headquartered in Green Island, New York, is the leading manufacturer of proprietary, high-performance UVC LEDs for monitoring, purification and sterilization applications in the water, food, air and healthcare industries. For more information, visit


Crystal IS, Inc.

Liz Solarek, 518-429-7380

Marketing Communications Specialist

Heartbeat Experts Reports Over 350% Year To Date Growth from the Emerging Markets

Revenue and Staff Expansion is highlighted for Brazil, Russia, India, China, and Korea

NEW YORK - Tuesday, May 28th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, announced today 350% year-over-year growth in emerging markets in the first quarter of 2013 compared to the same period in 2012.

The company reported expanding revenue across all the (BRICK) Brazil, India, China, Korea and Russia markets. Specifically Heartbeat saw significant growth in China where it significantly increased its user base for its stakeholder management software, data analytics solutions, and stakeholder data offering. Heartbeat also reported landing market access and reimbursement-focused projects for a range of new product launches in Latin America; and new client acquisitions with generics and biosimilar manufacturers in India, Korea and Russia.

Keren Priyadarshini, VP of Asia-Pacific, commented on the report noting, “In 2012 and early 2013 we opened four new offices in the region and greatly expanded our local team in China. China has represented a major milestone for our company, as we tripled the business development staff in 2013 from 2012. We are working with major multinational clients in China who are expanding the scope of their launches and growing their medical science liaison (MSL) teams. This has translated to larger project scopes and expansion of existing client engagements.”

Rosangela Deamo, VP of Latin America, added, “In Latin America and Brazil in particular, market access issues have dominated our client’s needs. We’re beginning to work with key clients for each of their new product launches, mapping the reimbursement and health economic landscape for each indication in each market. The growth in 2013 compared to 2012 reflects increases in new product launches coupled with the strong client relationships we’ve built.”

Heartbeat Experts reports planned expansions in emerging markets during 2013 with new offices in Buenos Aires, Warsaw and Istanbul.

About Heartbeat Experts:

Heartbeat Experts is the leading stakeholder management solution provider serving 20 of the top 20 pharmaceutical companies and 18 of the top 20 medical device companies. Heartbeat Experts provides software and data for KOL identification, KOL management, pricing and reimbursement, formulary access, regulatory affairs, a suite of stakeholder engagement products including virtual advisory boards, HCP communities and market research.


Heartbeat Experts

Joe Baumer, +1-212-941-9041


Tuesday, May 28, 2013

New European survey highlights ischaemic stroke protection as treatment priority for patients with atrial fibrillation

INGELHEIM, Germany - Tuesday, May 28th 2013 [ME NewsWire]

    Over two thirds of physicians point out preventing ischaemic stroke as the most important treatment goal for patients with atrial fibrillation (AF)1
    Physicians highlight the vital need for awareness of the true incidence of ischaemic stroke1
    92% of all strokes in patients with AF are ischaemic strokes2, making ischaemic stroke prevention a key treatment priority

(BUSINESS WIRE)-- Not intended for media in the UK, the US or Canada

New findings from a pan-European online survey of 1,000 physicians have demonstrated that for over two thirds of physicians, preventing ischaemic stroke is the most important treatment goal for patients with atrial fibrillation (AF).1 Ischaemic stroke is the most common type of stroke suffered by patients with AF2, and as such physicians across Europe have highlighted the vital need for increased awareness of the true incidence and impact in this patient population. The survey findings were announced in parallel with the European Stroke Conference in London (28th-31st May) and highlight the need for additional information and education about the risk and impact of ischaemic stroke on the lives of AF patients.

Every year, up to three million patients with AF have a stroke.3,4 92% of strokes in AF patients are ischaemic.2 They occur when a blood vessel supplying the brain with blood is blocked e.g. by a blood clot. This reduction or complete prevention of blood flow to the brain may result in severe and burdensome physical impairment, paralysis or even death.5 Atrial fibrillation is the most common sustained heart rhythm condition6 affecting approximately 2% of the total population.7 The condition leads to a five-fold increase in the risk of stroke.7

“Every physician who treats patients with atrial fibrillation needs to recognise the risk of ischaemic stroke in these patients,” commented Professor Hans-Christoph Diener, Professor of Neurology and Chairman of the Department of Neurology, University of Essen, Germany. “Today, we have great and new possibilities at hand to prevent many of these devastating events. It is our responsibility as treating physicians to identify the patients in need for stroke prevention through screening, diagnosis and risk assessment and then protect them as best as we can from the possible consequences of an ischaemic stroke or an intracranial haemorrhage.”

Cardiologists and general practitioners (GPs) in seven European countries were surveyed via a MedLIVE™ PULSE online survey to ascertain their perspectives on treatment priorities in AF. The survey explored factors affecting prescribing behaviours, such as the importance of stroke prevention in AF, the comparative need for treatment experience and convenience, and the perceived awareness of the incidence of ischaemic stroke. Key findings demonstrated:1

    67% of physicians state that preventing ischaemic stroke is the most important treatment goal for patients with AF
    84% of physicians highlight the vital need for awareness of the impact of ischaemic strokes for patients with AF, stating that the true incidence may be underestimatedi
    When questioned on important factors that affect prescribing decisions, 56% of physicians responded that protecting patients against ischaemic stroke is the single most important factor affecting their prescribing decisions, followed by general treatment efficacy (protection against all strokes) and treatment safety (minimising the risk of bleeding in patients)
    When asked which attributes were most important when choosing treatments for patients with AF, 50% of physicians stated that the availability of clinical data was the most important attribute to consider and 39% selected experience in clinical practice over the treatment’s convenience for daily management

“Ischaemic stroke is a real concern; not only because the risk is so high, but also because of the potential life-changing impact that it may have on patients with atrial fibrillation. Ischaemic strokes can be devastating for both patients and their families, and have a significant impact on their daily lives. They also increase healthcare utilisation and the need for long-term care,” stated Trudie Lobban, MBE, Founder & CEO of Atrial Fibrillation Association (AFA). “It is essential that more work is undertaken to raise awareness of the risk of ischaemic stroke and to ensure that patients with AF receive treatments that provide the most comprehensive protection.”

Appropriate anticoagulation therapy can help to prevent strokes experienced by patients with AF and improve overall outcomes.8 Major treatment guidelines in Europe, the US and worldwide recognise the benefits of anticoagulant treatments for stroke prevention in atrial fibrillation.9 Pradaxa® (dabigatran etexilate) 150mg bid is the only novel oral anticoagulant, for which its trial (RE-LY®ii, comparing Pradaxa® vs. warfarin) has shown a relevant reduction of ischaemic stroke: In patients with non-valvular AF, Pradaxa® 150mg reduced the risk for ischaemic stroke by 25% compared to warfarin.10,11 In addition, patients taking Pradaxa® 150mg had a 59% lower risk of intracranial bleeding, the most feared side-effect of anticoagulation.10,11

Overall in the RE-LY® trial, Pradaxa® 150mg bid provided a 35% reduction in the overall risk of stroke and systemic embolism versus warfarin.10,11 Pradaxa® 110mg bid was shown to be non-inferior compared to warfarin for the prevention of stroke and systemic embolism.10,11 Pradaxa® 150mg showed a similar risk of major bleeds versus warfarin and Pradaxa® 110mg bid demonstrated significantly lower major bleeding.10,11 Both doses of Pradaxa® were associated with significantly lower total, intracranial and life-threatening bleeding compared to warfarin.10,11

Monday, May 27, 2013

The 2013 AVAYA PDS & POM International User Group Conference & Expo

PITTSBURGH - Monday, May 27th 2013 [ME NewsWire]

(BUSINESS WIRE)-- The AVAYA PDS / POM User Group will be conducting its 22nd annual Conference & Expo at the Silverton Hotel & Casino Las Vegas, Nevada. September 16th, 17th and 18th 2013.

Topics include: AVAYA Presentations on outbound road map, multiple upcoming product releases for Proactive Contact & POM including: Proactive Contact 5.1, Proactive Contact 5.1 next steps, Proactive Outreach Manager (POM) 3.0, trouble shooting your system, regulatory updates and open forums. Raj Wadhwani, President of Contact Center World, will share "best practices".

The Silverton Hotel & Casino offers free shuttles to and from the airport and the Strip. We have secured a room rate of $50.00 Single or Double and in some cases, triple occupancy, for users that want to make a family vacation of it.

Meeting Agenda Summary*

-- Monday, September 16, 2013

6:30PM-10:00PM Cocktail Reception & Vendor Exposition*

-- Tuesday, September 17, 2013

8:00AM Breakfast, followed by user sessions.

-- Tuesday evening, September 17

Networking dinner event & early registration prize drawing

-- Wednesday, September 18, 2013

8:00AM Breakfast, followed by user sessions;

Gold Service Award given after lunch.

-- Wednesday, September 18, 2013

4:30PM Conference ends with door prize drawings.

*Vendor Exposition runs concurrently throughout conference

For more information go to:

Email: or call 1 724-947-5453.

Call Center vendors and suppliers wishing to display at the event must contact us by phone or email. Remember, space is very limited.

About The AVAYA PDS / POM User Group

AVAYA PDS USER GROUP Mission Statement To provide a vehicle for AVAYA predictive dialer users to increase their knowledge on proper operation, utilization, and maintenance of their systems and other call center solutions, in an environment conducive to networking


AVAYA Predictive Dialer & POM International User Group

Alex Demczak, 724-947-5453

O3b Networks Announces Innovative New Technology Which Increases O3b’s Throughput by up to 50%, Improves Availability and Interoperates with Standard Satellite Modems

ST. HELIER, Jersey, Channel Islands - Monday, May 27th 2013 [ME NewsWire]

(BUSINESS WIRE)-- O3b Networks announced today the introduction of ground breaking signal processing technology, 'MEO BoosterTM' which will offer even more advantage to customers when used with the soon to be launched high speed, low latency MEO constellation from O3b.

The new MEO BoosterTM improves performance by increasing throughput, leading to a lower cost per bit for the customer and making O3b truly fiber competitive. MEO BoosterTM in conjunction with standard O3b ground equipment enhances link efficiency, increasing link throughput by up to 50 per cent. The use of state of the art modulation techniques translates to availability improvements and world leading spectral efficiency under all conditions. MEO BoosterTM is a product designed and produced by EMC Satcom Technologies GmbH, one of O3b’s development partners.

“The MEO BoosterTM takes what is already the highest throughput, lowest latency satellite service for Carriers, Enterprise and Governments and improves throughput by between 30% and 50% while giving O3b’s customers a full range of off the shelf modems to choose from. The MEO BoosterTM also reduces the number of modems required in the customer design minimising investment and reducing complexity,” commented Dr. Ashok Rao, VP of Product Development for O3b Networks.

“We have existing customers today that will break records in satellite transmission reaching speeds of over 1 Gigabit per second in a single O3b link. This innovative technology pushes the boundaries even further, reaffirming O3b’s claim to the most spectrally and cost efficient links in the world,” said John Finney, Chief Commercial Officer for O3b Networks.

About O3b Networks Limited

O3b Networks Limited is a global satellite service provider building a next-generation satellite network for telecommunications operators, Internet service providers, enterprise and government customers in emerging markets. The O3b system will combine the global reach of satellite with the speed of a fiber‐optic network providing billions of consumers and businesses in nearly 180 countries with low‐cost, high‐speed, low latency Internet and mobile connectivity. O3b Networks’ investors include SES, Google, Liberty Global, HSBC Principal Investments, Northbridge Venture Partners, Allen & Company, Development Bank of Southern Africa, Sofina, Satya Capital and Luxempart. O3b Networks is headquartered in St. Helier, Jersey, Channel Islands.

About EMC Satcom Technologies GmbH

EMC Satcom Technologies GmbH, an affiliated company of the global provider Emerging Markets Communications (EMC), is a technology innovator holding a number of patents achieving ground breaking optimization of satellite VSAT links and networks. In addition to inventing, producing and deploying this technology, EMC Satcom also integrates it into networks worldwide. For more information, please visit or email James Alderdice at


O3b Networks

Luisa Sorrentino

VP, Marketing Communications

+31 629508524

Gemalto supplies MTS Russia with UpTeq NFC SIM for mobile transport services

AMSTERDAM - Monday, May 27th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Gemalto (Euronext NL 0000400653 GTO), the world leader in digital security, is supplying Mobile TeleSystems (MTS), Russia’s largest network operator with over 70 million subscribers, with its UpTeq NFC high-end SIM cards for a mobile phone-based public transport ticketing solution in the city of Novosibirsk. Produced and personalized at Gemalto’s Moscow service center, the solution can deliver increased efficiency and responsiveness for the swift deployment of MTS’ NFC program. Gemalto uniquely provides its Russian customers with deep expertise and local presence across telecommunications, banking and transport sectors.

Operated alongside Zolotaya Korona, a Russian payment and money transfer system, the ticketing service allows users to pay for journeys on buses and the metro in Novosibirsk, the country’s third-largest city, simply by tapping their mobile phone on an NFC reader. For optimum convenience, users will be charged for journeys via their regular MTS billing scheme. Over 95% of public transport turnstiles and terminals in Novosibirsk are already equipped with NFC readers and the new system is designed to replace the current paper tickets. Queuing will become shorter for customers and the traveling experience will improve across the entire public transport network, throughout the city.

“As NFC technology moves beyond the realms of contactless payment, transportation is emerging as one of the most important applications, and our Upteq NFC SIM is the ideal platform to deploy a wider range of services in the future,” said Thierry Mesnard, Senior Vice President at Gemalto. “High profile deployments such as the MTS project in Novosibirsk will have a significant impact, getting end users accustomed to tapping their mobile phone to enjoy NFC services.”

“Will 2013 be the year of NFC? My response is yes, it is. We have reached a point of no return, from where NFC will be included within companies' products, apps, and services. The installed base will grow to half a billion devices and beyond. That provides you and me with an increasing variety of things to tap our phones with,” added John Devlin, principal analyst with ABI Research.

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the world leader in digital security with 2012 annual revenues of €2.2 billion and more than 10,000 employees operating out of 83 offices and 13 Research & Development centers, located in 43 countries.

We are at the heart of the rapidly evolving digital society. Billions of people worldwide increasingly want the freedom to communicate, travel, shop, bank, entertain and work – anytime, everywhere – in ways that are enjoyable and safe. Gemalto delivers on their expanding needs for personal mobile services, payment security, authenticated cloud access, identity and privacy protection, eHealthcare and eGovernment efficiency, convenient ticketing and dependable machine-to-machine (M2M) applications. We develop secure embedded software and secure products which we design and personalize. Our platforms and services manage these products, the confidential data they contain and the trusted end-user services made possible.

Our innovations enable our clients to offer trusted and convenient digital services to billions of individuals. Gemalto thrives with the growing number of people using its solutions to interact with the digital and wireless world.

For more information visit,,, or follow @gemalto on Twitter.


Gemalto Media Contacts:

Peggy Edoire, +33 4 42 36 45 40

Europe, Middle East & Africa

Pierre Lelievre, +65 6317 3802

Asia Pacific

Nicole Smith, +1 512-758-8921

North America

Ernesto Haikewitsch, +55 11 5105 9220

Latin America

Bangkok Peaks as World's Top Travel Hotspot

 Asia Pacific Region Notable Trend in MasterCard’s 2013 Global Destination Cities Index

BANGKOK - Monday, May 27th 2013 [ME NewsWire]

To tweet this news, copy and paste to your Twitter handle with the hashtags #MasterCard and #DestinationCities

(BUSINESS WIRE/ME NewsWire)-- Today, in launching its third annual Global Destination Cities Index, MasterCard announced that Bangkok is this year’s number one city for travel. While London reached the top spot in 2012, it was edged by the slimmest of margins with only about 25,000 visitors separating the two – a difference of about one percent. The study looked at the highest international visitor numbers in 2013, with London, Paris, Singapore, and New York rounding out the top five.

A noticeable trend in this year’s report was the dominance of the Asia/Pacific region. Of the 132 cities ranked, 42 are Asian countries. Bangkok is followed by Singapore, Kuala Lumpur, Hong Kong, Seoul, Shanghai, Tokyo, and five of the top 10 in 2013 are in the Greater China region.

“With the rise of the Asia/Pacific region, this year’s index reflects the rebalance that the globe is undergoing in large part because of the rise of emerging markets,” said Ann Cairns, President of International Markets, MasterCard Worldwide. “This shift is further underscored by electronic payments, which are enabling more people from more places to participate in the global economy than ever before.”

Of the 20 highest-ranked Destination Cities for 2013, four of the top five are MasterCard Priceless Cities: London, Paris, Singapore, and New York with Los Angeles coming in at 20. Not only are these cities attracting international visitor arrivals, they’re top spots for residents as well.

About Bangkok’s number one ranking, Mr. Thawatchai Arunyik, Deputy Governor for Domestic Marketing, Tourism Authority of Thailand said, “The Thailand tourism slogan – ‘Amazing Thailand Always Amazes You’ – is certainly apt as its capital, Bangkok, has emerged at the top of this year’s index. And the word ‘Amazing’ focuses on the interest of foreign tourists towards the country of Thailand. What a tribute this is to our city’s hospitality industry, the transport industry and food and beverage and catering industry and more.”

“Bangkok brought with it great momentum from last year. Its ascent to number one is not only a first for Asia, it’s emblematic of the rise of the Global South which encompasses much of Africa and Asia as well as South America,” Dr. Yuwa Hedrick-Wong, Global Economic Advisor for MasterCard and author of the report.

The MasterCard Index of Global Destination Cities ranks cities in terms of the number of their total international visitor arrivals and the cross-border spending by these same visitors in the destination cities, and gives visitor and passenger growth forecasts for 2013.

Public data are used in deriving the international visitor arrivals and their cross-border spending in each of the 132 destination cities, using custom-made algorithms; paying special attention to eliminate the hub effects for destination cities such as Singapore, Amsterdam and Frankfurt.

This Index and the accompanying reports are not based on MasterCard volumes or transactional data.

About MasterCard

MasterCard (NYSE: MA),, is a technology company in the global payments industry. We operate the world’s fastest payments processing network, connecting consumers, financial institutions, merchants, governments and businesses in more than 210 countries and territories. MasterCard’s products and solutions make everyday commerce activities – such as shopping, traveling, running a business and managing finances – easier, more secure and more efficient for everyone. Follow us on Twitter @MasterCardNews, join the discussion on the Cashless Conversations Blog and subscribe for the latest news.


MasterCard Worldwide

Marcy Cohen, 914-249-2214


Sunday, May 26, 2013

Lenovo Reports Strong Fourth Quarter and Full Year 2012/13 Results

Rapid PC Plus Transformation and Effective Cost Control Drive 90 Percent Profit Growth in Q4

HONG KONG - Sunday, May 26th 2013 [ME NewsWire]

    Records in annual pre-tax income of US$801 million and earnings of US$635 million
    Record annual sales of US$34 billion
    Record 52.4 million PC shipments and record 15.5 percent global market share
    Full year basic EPS of 6.16 US cents, or 47.78 HK cents
    Net cash reserves of US$3.1 billion (as of March 31, 2013)

(BUSINESS WIRE)-- Lenovo Group today announced results for its fourth fiscal quarter and full-year ended March 31, 2013. With record full-year sales of US$34 billion, an increase of 15 percent year-over-year, a record full-year pre-tax income of US$801 million, up 38 percent year-over-year and record earnings of US$635 million, up 34 percent, Lenovo had a strong showing. While Lenovo continued to close in on the #1 position in PCs, with a record 15.5 percent market share for the full-year, it accelerated its transformation to become a top competitor in the PC Plus era, with a 5.9 percent share of Smart Connected Devices and global #3 ranking.

Lenovo had record revenues for the fourth quarter of US$7.8 billion, four percent year-over-year growth. The Company achieved pre-tax income of US$166 million during the fourth fiscal quarter, a 63 percent increase over the same period last year. Compared to an overall industry decline of more than 13 percent year-over-year, Lenovo grew at a 14 point premium to the market, besting the industry for the 16th quarter in a row.

The Company’s gross profit for the fourth fiscal quarter grew to US$963 million, an increase of 20 percent year-over-year. Gross margin was 12.3 percent. Operating profit for the fourth quarter was US$169 million, up 67 percent year-over-year, while earnings jumped 90 percent year-over-year to US$127 million.

Basic earnings per share in the fourth fiscal quarter are 1.22 US cents, or 9.46 HK cents. Lenovo’s Board of Directors declared a final dividend of 1.81 US cents, or 14.0 HK cents per share for the fiscal year ended March 31, 2013.

For the 2012/13 fiscal year, Lenovo’s PC shipments grew 10.2 percent year-over-year, compared to an overall industry decline of 8.1 percent during this same period. Gross profit for the full year was US$4.1 billion, an increase of 18 percent year-over-year. Gross margin was 12 percent, while operating profit for the full fiscal year was US$ 800 million, a 37 percent jump over year-over-year. Lenovo’s earnings grew 34 percent year-over-year to US$635 million.

“Despite a challenging macro-economic environment and ongoing PC industry transformation, Lenovo delivered a strong performance in the 2012/13 fiscal year. Not only were we the fastest growing among all major PC players, with record market share, revenue and profitability, more importantly, our smartphone and tablet businesses saw dramatic growth,” said Yang Yuanqing, Lenovo Chairman and CEO. “In fact, smartphone shipments were 3.7 times greater than last year globally and we are now number two in the China smartphone market. This has laid a solid foundation for the successful transformation of Lenovo into a PC Plus leader. Going forward, we will focus our investments on the fast-growing tablet, smartphone and enterprise hardware areas, while working to enhance the profitability of our core PC business. We are very confident in our ability to achieve success in these new areas, just as in the PC business.”


    Lenovo China achieved a 4.9 percent operating margin on US$3.1 billion in consolidated sales in the fourth fiscal quarter. This was an eight percent year-over-year or US$228 million increase of revenue, accounting for 40 percent of the Company’s worldwide sales. Lenovo’s PC Plus push was strongest in China with 74 percent MIDH revenue growth and a revenue contribution in China of 21 percent. MIDH’s profitability also continued to improve. Lenovo grew its number-one PC market share position in China, the world’s largest PC market, to 31.7 percent, up 1.7 points year-over-year. Lenovo’s PC shipments in China benefited from its deep penetration in emerging cities and the country’s ongoing urbanization.
    In the Asia Pacific/Latin America region, Lenovo achieved 11.7 percent market share in the fourth fiscal quarter, up 1.1 points. With the regional PC market that was down 8.5 percent year-over-year, the Company grew its PC shipments across the region by one percent. Lenovo remained number one in Japan and increased its lead over the competition. Consolidated sales across the region totaled US$1.7 billion or 21 percent of Lenovo’s worldwide sales, while operating margins were profitable.
    Lenovo in Europe, Middle East & Africa grew PC shipments during the fourth quarter by 11 percent and continued to strengthen its number two position in PCs across the region, with 11.8 percent market share, an increase of 3.2 share points year-over-year. This is a 30 point premium to the market that saw a 19.5 percent decline in the region. The Company had consolidated sales in the fourth quarter of US$1.8 billion, a year-over-year improvement of six percent, good for 24 percent of Lenovo’s total worldwide sales. Operating profit margin was healthy at 2.3 percent, a 1.4 point increase year-over-year.
    Lenovo’s PC shipments in North America in the fourth fiscal quarter increased 9.8 percent year-over-year, in a market that fell by about 12 percent. In this environment, the Company gained 1.8 share points to a record high market share of 9.3 percent. Consolidated sales grew 13 percent year-over-year to US$1.2 billion in the fourth quarter, or 15 percent of Lenovo’s total worldwide sales. In North America, Lenovo continues to have success in the high-end convertible consumer space, with devices like Yoga and Twist taking the number 1 position with nearly 50 percent market share.


    Consolidated sales for Lenovo’s laptop PC business worldwide in the fourth fiscal quarter decreased two percent year-over-year to US$4.2 billion, accounting for 53 percent of the Company’s overall sales. During the same period, Lenovo’s worldwide laptop PC shipments increased 0.4 percent, against the backdrop of an overall industry decrease of 14.2 percent. In the fourth quarter, Lenovo introduced several new consumer laptop PCs, led by the IdeaPad U310 and U410, mainstream thin and light Ultrabooks with 10-finger touch, and the IdeaPad Z400 and Z500 “entertainment-optimized” laptop PCs, featuring an immersive sound experience. For business customers, Lenovo introduced the new ThinkPad T431s, the thinnest “T-series” ever, the T-series being Lenovo’s highest selling laptop line.
    During the fourth fiscal quarter, Lenovo’s desktop PC shipments held flat worldwide year-over-year, against an industry decline of 12.2 percent worldwide. Lenovo’s desktop PC consolidated sales for the same period decreased two percent to US$2.4 billion, or 30 percent of the Company’s overall sales worldwide. In the fourth quarter, Lenovo introduced Horizon, an all-in-one table PC and the Company’s first “interpersonal PC,” a multi-user, multi-touch, multi-mode device for the home that allows users to turn their personal computing experience into a shared computing experience.
    Lenovo held strong as China’s number two smartphone maker, seeing rapid growth in all its Mobile Internet Digital Home (MIDH) product lines. The Company’s smartphone shipments grew 206 percent in the fourth quarter, a significant premium to the overall market in China which grew 117 percent. This equates to a 3.5 year-over-over share point gain, or a fourth quarter market share of 13 percent. Consolidated sales of MIDH products rose 74 percent to US$736 million, nine percent of the Company’s overall sales. Lenovo announced several new smartphones in the fourth quarter, led by the new K900, a premium 5.5-inch smartphone, with a super-slim 6.9 mm profile and high-performance camera; all running on an Intel Atom processor.


Lenovo (HKSE: 0992) (PINK SHEETS: LNVGY) is a US$34 billion personal technology company – one of the top two PC makers in the world and an emerging PC Plus leader – serving customers in more than 160 countries. Dedicated to exceptionally engineered PCs and mobile internet devices, Lenovo’s business is built on product innovation, a highly-efficient global supply chain and strong strategic execution. Formed by Lenovo Group’s acquisition of the former IBM Personal Computing Division, the Company develops, manufactures and markets reliable, high-quality, secure and easy-to-use technology products and services. Its product lines include legendary Think-branded commercial PCs and Idea-branded consumer PCs, as well as servers, workstations, and a family of mobile internet devices, including tablets and smart phones. Lenovo, a global Fortune 500 company, has major research centers in Yamato, Japan; Beijing, Shanghai and Shenzhen, China; and Raleigh, North Carolina. For more information see

To view the full report and tables please click here.



Hong Kong:

Angela Lee, +852 2516 4810


Eric Guo, +8610 5886 6114

United States:

Brion Tingler, +1 917 528 1992


Saturday, May 25, 2013

Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer

ME Newswire / Business Wire

BOUDRY, Switzerland - Saturday, May 25th 2013

European Medicines Agency Accepts Regulatory Submission of Type II Variation for ABRAXANE for the Treatment of Advanced Pancreatic Cancer

Celgene International Sàrl, a subsidiary of Celgene Corporation (Celgene) (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) for the use of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first–line treatment of patients with advanced pancreatic cancer.

The FDA grants Priority Review to medicines that, if approved, have the potential to offer significant improvement compared to marketed products or provide a treatment where no adequate therapy exists. The goal for completing a Priority Review is six months. The Prescription Drug User Fee Act (PDUFA) date for the sNDA for ABRAXANE is set for September 21, 2013.

In April 2013, the European Medicines Agency (EMA) has also accepted for review a Type II Variation to the current Marketing Authorization Application (MAA) for ABRAXANE, in combination with gemcitabine, for the first–line treatment of patients with advanced pancreatic cancer. Celgene plans to submit dossiers for registration in other countries/regions during 2013.

Both applications included data from an open-label, phase III, randomized, international study, Metastatic Pancreatic Adenocarcinoma Clinical Trial (MPACT) involving 861 patients with metastatic pancreatic cancer. Results from this study were recently presented at the American Society of Clinical Oncology’s (ASCO) 2013 Gastrointestinal Cancers Symposium in January.

Celgene is preparing a development plan for a phase III, international, multicenter, randomized controlled trial evaluating the activity of ABRAXANE plus gemcitabine in the adjuvant pancreatic cancer setting.

ABRAXANE is not currently approved for the treatment of advanced pancreatic cancer.

About Pancreatic Cancer

Pancreatic cancer is the eighth leading cause of cancer-related death worldwide and the fourth leading cause of cancer-related death in the US. The pancreas is composed of two main cell types: exocrine and endocrine. Exocrine tumors are by far the most common type of pancreatic cancer, with adenocarcinoma accounting for about 95 percent of cancers of the pancreas. For all stages of pancreatic cancer combined, the 5-year overall survival rate is about 6 percent, which is the lowest 5-year overall survival rate of any cancer in the US. In Europe, the reported survival rate is less than 10 percent survival at five years.


ABRAXANE is an albumin-bound form of paclitaxel that is manufactured using patented nab® technology. ABRAXANE is formulated with albumin, a human protein, and is free of solvents.

In the United States, ABRAXANE was first approved in January 2005 for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. ABRAXANE is also approved in Canada, India, European Union/European Economic Area (EU/EEA), South Korea, China, Australia, Bhutan, United Arab Emirates, Nepal, New Zealand, Japan, Russia, Sri Lanka, and Argentina for the treatment of metastatic breast cancer.

In October 2012, ABRAXANE was approved by the FDA for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy. ABRAXANE is also approved in Japan and Argentina for the treatment of non-small cell lung cancer and is approved in Japan for the treatment of gastric cancer.

ABRAXANE is currently in various stages of investigation for the potential treatment of the following cancers: melanoma, bladder, ovarian, and expanded applications for breast, lung, and pancreatic cancer.

U.S. Regulatory Information for ABRAXANE

ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension)(albumin-bound) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

ABRAXANE is indicated for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.

Important Safety Information


    Do not administer ABRAXANE therapy to patients who have baseline neutrophil counts of less than 1,500 cells/mm3. In order to monitor the occurrence of bone marrow suppression, primarily neutropenia, which may be severe and result in infection, it is recommended that frequent peripheral blood cell counts be performed on all patients receiving ABRAXANE
    Note: An albumin form of paclitaxel may substantially affect a drug’s functional properties relative to those of drug in solution. DO NOT SUBSTITUTE FOR OR WITH OTHER PACLITAXEL FORMULATIONS


Neutrophil Counts

    ABRAXANE should not be used in patients who have baseline neutrophil counts of < 1,500 cells/mm3


    Patients who experience a severe hypersensitivity reaction to ABRAXANE should not be rechallenged with the drug


Hematologic Effects

    Bone marrow suppression (primarily neutropenia) is dose-dependent and a dose-limiting toxicity of ABRAXANE. In clinical studies, Grade 3-4 neutropenia occurred in 34% of patients with metastatic breast cancer (MBC) and 47% of patients with non-small cell lung cancer (NSCLC)
    Monitor for myelotoxicity by performing complete blood cell counts frequently, including prior to dosing on Day 1 for MBC and Days 1, 8, and 15 for NSCLC
    Do not administer ABRAXANE to patients with baseline absolute neutrophil counts (ANC) of less than 1,500 cells/mm3
    In the case of severe neutropenia (<500 cells/mm3 for 7 days or more) during a course of ABRAXANE therapy, reduce the dose of ABRAXANE in subsequent courses in patients with either MBC or NSCLC
    In patients with MBC, resume treatment with every-3-week cycles of ABRAXANE after ANC recovers to a level >1,500 cells/mm3 and platelets recover to >100,000 cells/mm3
    In patients with NSCLC, resume treatment if recommended at permanently reduced doses for both weekly ABRAXANE and every-3-week carboplatin after ANC recovers to at least 1,500 cells/mm3 and platelet count of at least 100,000 cells/mm3 on Day 1 or to an ANC of at least 500 cells/mm3 and platelet count of at least 50,000 cells/mm3 on Days 8 or 15 of the cycle

Nervous System

    Sensory neuropathy is dose- and schedule-dependent
    The occurrence of Grade 1 or 2 sensory neuropathy does not generally require dose modification
    If ≥ Grade 3 sensory neuropathy develops, treatment should be withheld until resolution to Grade 1 or 2 for MBC or until resolution to ≤ Grade1 for NSCLC followed by a dose reduction for all subsequent courses of ABRAXANE


    Severe and sometimes fatal hypersensitivity reactions, including anaphylactic reactions, have been reported
    Patients who experience a severe hypersensitivity reaction to ABRAXANE should not be re-challenged with this drug

Hepatic Impairment

    Because the exposure and toxicity of paclitaxel can be increased with hepatic impairment, administration of ABRAXANE in patients with hepatic impairment should be performed with caution
    The starting dose should be reduced for patients with moderate or severe hepatic impairment

Albumin (Human)

    ABRAXANE contains albumin (human), a derivative of human blood

Use in Pregnancy: Pregnancy Category D

    ABRAXANE can cause fetal harm when administered to a pregnant woman
    If this drug is used during pregnancy, or if the patient becomes pregnant while receiving this drug, the patient should be apprised of the potential hazard to the fetus
    Women of childbearing potential should be advised to avoid becoming pregnant while receiving ABRAXANE

Use in Men

    Men should be advised not to father a child while receiving ABRAXANE


Randomized Metastatic Breast Cancer (MBC) Study

    The most common adverse reactions (≥20%) with single-agent use of ABRAXANE vs. Paclitaxel injection in the MBC study were alopecia (90%, 94%), neutropenia (all cases 80%,82%; severe 9%,22%), sensory neuropathy (any symptoms 71%, 56%; severe 10%, 2%), abnormal ECG (all patients 60%, 52%; patients with normal baseline 35%, 30%), fatigue/asthenia (any 47%, 39%; severe 8%, 3%), myalgia/arthralgia (any 44%, 49%; severe 8%, 4%), AST elevation (any 39%, 32%), alkaline phosphatase elevation (any 36%, 31%), anemia (all cases 33%, 25%; severe 1%, <1%), nausea (any 30%, 22%; severe 3%, <1%), diarrhea (any 27%, 15%; severe <1%, 1%) and infections (24%, 20%), respectively
    Sensory neuropathy was the cause of ABRAXANE discontinuation in 7/229 (3%) patients
    Other adverse reactions of note with the use of ABRAXANE vs. Paclitaxel injection included vomiting (any 18%,10%; severe 4%, 1%), fluid retention (any 10%,8%; severe 0%,<1%); mucositis (any 7%, 6%; severe <1%, 0%), hepatic dysfunction (elevations in bilirubin 7%, 7%), hypersensitivity reactions (any 4%,12%; severe 0%, 2%), thrombocytopenia (any 2%, 3%; severe <1%, <1%), and injection site reactions (<1%, 1%), respectively. Dehydration and pyrexia were also reported
    Renal dysfunction (any 11%, severe 1%) were reported in patients treated with ABRAXANE (n = 229)
    In all ABRAXANE treated patients (n=366) ocular/visual disturbances were reported (any 13%; severe 1%)
    Severe cardiovascular events possibly related to single-agent ABRAXANE occurred in approximately 3% of patients and included cardiac ischemia/infarction, chest pain, cardiac arrest, supraventricular tachycardia, edema, thrombosis, pulmonary thromboembolism, pulmonary emboli, and hypertension
    Cases of cerebrovascular attacks (strokes) and transient ischemic attacks have been reported

Non-Small Cell Lung (NSCLC) Cancer Study

    Adverse reactions with a difference of ≥2%, Grade 3 or higher, with combination use of ABRAXANE and carboplatin vs. combination use of Paclitaxel injection and carboplatin in NSCLC were anemia (28%, 7%); neutropenia (47%, 58%); thrombocytopenia (18%, 9%), peripheral neuropathy (3%, 12%), and peripheral edema (0%, <1%), respectively
    Adverse reactions with a difference of ≥5%, Grades 1-4, with combination use of ABRAXANE and carboplatin vs. combination use of Paclitaxel injection and carboplatin in NSCLC were anemia (98%,91%), neutropenia (85%, 83%), thrombocytopenia (68%, 55%), peripheral neuropathy (48%, 64%), peripheral edema (10%, 4%), and epistaxis (7%, 2%), respectively
    The most common adverse reactions (≥20%) of ABRAXANE in combination with carboplatin for NSCLC were anemia, neutropenia, thrombocytopenia, alopecia, peripheral neuropathy, nausea, and fatigue
    The most common serious adverse reactions of ABRAXANE in combination with carboplatin for NSCLC were anemia (4%) and pneumonia (3%)
    The most common adverse reactions resulting in permanent discontinuation of ABRAXANE were neutropenia (3%), thrombocytopenia (3%), and peripheral neuropathy (1%)
    The most common adverse reactions resulting in dose reduction of ABRAXANE were neutropenia (24%), thrombocytopenia (13%), and anemia (6%)
    The most common adverse reactions leading to withholding or delay in ABRAXANE dosing were neutropenia (41%), thrombocytopenia (30%), and anemia (16%)
    The following common (≥10% incidence) adverse reactions were observed at a similar incidence in ABRAXANE plus carboplatin-treated and paclitaxel injection plus carboplatin-treated patients: alopecia 56%, nausea 27%, fatigue 25%, decreased appetite 17%, asthenia 16%, constipation 16%, diarrhea 15%, vomiting 12%, dyspnea 12%, and rash 10% (incidence rates are for the ABRAXANE plus carboplatin treatment group)

Post-marketing Experience with ABRAXANE and Other Paclitaxel Formulations

    Severe and sometimes fatal hypersensitivity reactions have been reported with ABRAXANE. The use of ABRAXANE in patients previously exhibiting hypersensitivity to paclitaxel injection or to human albumin has not been studied
    There have been reports of congestive heart failure and left ventricular dysfunction with ABRAXANE, primarily among individuals with underlying cardiac history or prior exposure to cardiotoxic drugs
    There have been reports of extravasation of ABRAXANE. Given the possibility of extravasation, it is advisable to monitor closely the ABRAXANE infusion site for possible infiltration during drug administration


    Caution should be exercised when administering ABRAXANE concomitantly with medicines known to inhibit or induce either CYP2C8 or CYP3A4


Nursing Mothers

    It is not known whether paclitaxel is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother


    The safety and effectiveness of ABRAXANE in pediatric patients have not been evaluated


    No toxicities occurred notably more frequently among patients ≥65 years of age who received ABRAXANE for MBC
    Myelosuppression, peripheral neuropathy, and arthralgia were more frequent in patients ≥65 years of age treated with ABRAXANE and carboplatin in NSCLC

Renal Impairment

    The use of ABRAXANE has not been studied in patients with renal impairment


    Dose adjustment is recommended for patients with moderate and severe hepatic impairment and patients who experience severe neutropenia or severe sensory neuropathy during treatment with ABRAXANE
    Withhold ABRAXANE if AST >10 x ULN or bilirubin >5 x ULN
    Dose reductions or discontinuation may be needed based on severe hematologic or neurologic toxicities
    Monitor patients closely

Please see full Prescribing Information, including Boxed WARNING, CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS, and ADVERSE REACTIONS, please visit

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

Celgene International Sárl, located in Boudry, Switzerland, is a wholly owned subsidiary and international headquarters of Celgene Corporation. For more information, please visit the Company's website at

Forward-Looking Statements

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.


For Celgene International Sàrl

Investors: +41 32 729 8303

Media: +41 32 729 8304

Boehringer Ingelheim and Eli Lilly & Company launch type 2 diabetes educational game, “Complications Combat”

INGELHEIM, Germany - Friday, May 24th 2013 [ME NewsWire]

(BUSINESS WIRE)-- For Non-U.S. and Non-UK media

Boehringer Ingelheim and Eli Lilly & Company have today launched an educational digital game for type 2 diabetes called Complications Combat. The game, available for desktop and iPad users, is designed to raise awareness of the many complications associated with type 2 diabetes and the challenges physicians and patients face when considering and managing these on a daily basis.

“The aim and design of the game is simple,” said Arnd Prilipp, Launch and Established Products CVM Boehringer Ingelheim. “However, effective management of type 2 diabetes and its complications is not. To simulate this, players are tasked with simultaneously saving the healthy lifestyle items whilst combating the many complications – and it is not easy.”

The objective of the game is to effectively manage type 2 diabetes and its complications by clicking or swiping the complications and ‘friends’, which are the healthy steps for managing the condition, to the correct side of the screen to maintain optimal patient health for as long as possible. During the course of the game, the user learns about the diverse range of complications that can be associated with type 2 diabetes and also about positive lifestyle choices that can help combat the progression of the disease. As the game becomes increasingly difficult, the user learns just how challenging it can be for physicians and patients to take all of these complications and lifestyle choices into consideration at the same time.

Uncontrolled type 2 diabetes can lead to hyperglycaemia which, if untreated in the long-term, can cause serious medical complications in all parts of the body.1 Diabetes-related complications include cardiovascular disease, stroke, kidney disease, eye problems and foot ulcers.2

Complications Combat can be played at and iPad users can download the free touchscreen app at


Please click on the link below for ‘Notes to Editors’ and ‘References’:


Boehringer Ingelheim GmbH

Arnd Prilipp

Launch and Established Products CVM


Phone: +49 (6132) 77-2091


Lilly Diabetes

Tammy Hull

Communications Manager


Phone: (317) 651-9116

MEF Launches Service Operations Committee to Improve Ethernet Processes

Service Operations Committee to streamline buying, selling, delivering and operating Carrier Ethernet services

MOUNTAIN VIEW, Calif - Friday, May 24th 2013 [ME NewsWire]

(BUSINESS WIRE)-- The MEF has launched the Service Operations Committee (SOC), the organization’s first new committee in eight years, joining the existing technical, marketing and certification committees.

The purpose of the Service Operations Committee, which has widespread support from MEF members, is to “define, streamline and standardize processes for buying, selling, delivering and operating MEF-defined services”. Allan Langfield (Comcast) and Shahar Steiff (PCCW Global) have been appointed as committee co-chairs.

For service providers, this new committee means more consistent contracts and clarification of different providers’ capabilities, a standardized ordering process that takes into account national regulatory factors as well as the greater diversity of Ethernet services over those of TDM services. In addition, service providers will benefit from accelerated negotiation and deployment of services.

“Our internal survey concluded that two thirds of our members favor the new committee and its associated benefits,” said Ihab Tarazi, MEF chairman of the board and Verizon’s vice president of product technology. “Carrier Ethernet 2.0, and notably E-Access, have done a great deal to streamline the technical issues aligning wholesale carrier Ethernet services, and now it is time to bring the business processes into alignment. This is a significant development for the MEF and will require greater participation by higher level executives with operational roles in addition to the technical contributions from MEF members.”

The initial goal will be to increase the consistency of services available from providers and to reduce the number of service descriptions in contracts to simplify the purchasing process. The ordering process also will be simplified by greater global consistency among order field names and values. Service providers will benefit from the streamlined ordering process and reduced cost of providing the same information to different providers.

Wiki-based collaboration tools, online meetings and physical meetings will be used to encourage global participation in the working group.

“We have created this new team to explore how the MEF can facilitate the industry’s implementation of Ethernet,” said Nan Chen, president, MEF. “This is the MEF’s second major initiative this year in addition to the newly launched CloudEthernet Forum that addresses the specific challenges of pure Ethernet cloud delivery across large and geographically dispersed datacenters.”

About The MEF:

The MEF is a global industry alliance comprising more than 210 organizations including telecommunications service providers, cable MSOs, network equipment/software manufacturers, semiconductors vendors and testing organizations. The MEF’s mission is to accelerate the worldwide adoption of Carrier-class Ethernet networks and services. The MEF develops Carrier Ethernet technical specifications and implementation agreements to promote interoperability and deployment of Carrier Ethernet worldwide.

For more information about the Forum, including a complete listing of all current MEF members, please visit the MEF web site at


USA & International PR:

Zonic Group PR

Roland Daniells

+44 (0)870 760 9248



UWE Scholz

+49 172 3988 114

Asia Pacific:

Zonic PR Asia

Shirley Yeh

+86 21 321 00018

Friday, May 24, 2013

MEF: Industry Moves to Enhance Ethernet for the Cloud

CloudEthernet Forum launched with close MEF collaboration

MOUNTAIN VIEW, Calif - Friday, May 24th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Launched today, the CloudEthernet Forum addresses the specific issues of scaling and applying suitable Ethernet services to meet the stringent demands of delivering cloud services.

With virtual machine populations running into the millions across geographically dispersed datacenters plus the migration of storage networks to Ethernet, the Forum provides a unique framework for industry stakeholders to collectively develop solutions that address technical challenges such as VLAN scaling, layer 2 performance and resilience across very large domains and consolidating storage network technologies onto Ethernet.

James Walker, president of the CloudEthernet Forum and vice president of Managed Network Services, Tata Communications, explains how the Forum is addressing real concerns, “Four years ago we migrated our Ethernet services over SDH to native Ethernet over PBB and it is proving highly popular with our datacenter customers. They love Ethernet’s simplicity and scalability and want more. However, as datacenter networks become larger and more sophisticated, they are coming up against challenges, and the CloudEthernet Forum is committed to resolving those issues.”

Ultimately, the work of the CloudEthernet Forum enables cloud service providers, carriers and enterprises to quickly and simply build and manage very large amounts of computing and storage capacity to meet the rapidly changing localized performance, scalability and regulatory requirements of cloud services, all while optimizing operational costs. Just as the MEF has enhanced and standardized Carrier Ethernet to create services suitable for geographically-dispersed enterprises and mobile operators worldwide, the CloudEthernet Forum will work to develop Ethernet to enable collections of millions of virtual servers and storage devices to perform reliably and efficiently across both regional and global networks.

"Establishment of the CloudEthernet Forum is a reflection of Ethernet's critical position in the future of the communications industry," says Ihab Tarazi, chairman of the board of the MEF and vice president of product technology at Verizon. "Ethernet is ideal for delivering dynamic high speed bandwidth for public and private clouds with reliability, scalability and high performance."

“Solutions from the CloudEthernet Forum will increase demand for Carrier Ethernet services –aligning it closely with the MEF’s objectives and mission to accelerate the adoption of carrier-class Ethernet globally,” says Nan Chen, president of the MEF.

The founding members of the CloudEthernet Forum include: Alcatel-Lucent, Avaya, Equinix, HP, Juniper Networks, PCCW Global, Spirent Communications, Tata Communications and Verizon. The CloudEthernet Forum is an MEF organization but will operate independently. New members such as systems integrators, NEMs and service providers, including leading cloud providers, are encouraged to join.

For more information, the latest CloudEthernet Forum news and membership details, see

About The CloudEthernet Forum:

The CloudEthernet Forum is a global industry alliance founded in May 2013 to address the need for scaling and enhancing Ethernet technology to meet the stringent demands of delivering cloud services. The membership will include systems integrators, NEMs and service providers including leading cloud providers – the eleven founder members being: Alcatel-Lucent, Avaya, Citrix, Equinix, Huawei, HP, Juniper, PCCW Global, Spirent Communications, Tata Communications and Verizon. The Forum’s mission is to help cloud service providers, carriers and enterprises to support cloud services more easily, quickly and economically.

The CloudEthernet Forum is an independent MEF organization. For more information, please visit

About The MEF:

The MEF is a global industry alliance comprising more than 210 organizations including telecommunications service providers, cable MSOs, network equipment/software manufacturers, semiconductors vendors and testing organizations. The MEF’s mission is to accelerate the worldwide adoption of Carrier-class Ethernet networks and services. The MEF develops Carrier Ethernet technical specifications and implementation agreements to promote interoperability and deployment of Carrier Ethernet worldwide.

For more information about the Forum, including a complete listing of all current MEF members, please visit the MEF web site at


MEF PR contact:

Zonic Group PR

Roland Daniells

+44 (0)870 760 9248

CloudEthernet Forum PR Contact:

Zonic Group PR

Kate Innes

+44 (0)1672 550123

GLIDE’s Annual eBay Auction for Power Lunch with Warren Buffett, June 2 – 7, 2013

SAN FRANCISCO - Thursday, May 23rd 2013 [ME NewsWire]

(BUSINESS WIRE)-- Warren Buffett, legendary investor and philanthropist, will host his one-and-only charity power lunch to benefit one of the country’s most respected and beloved charities, San Francisco’s GLIDE, who is celebrating its 50th year of supporting the City’s neediest residents. Now in its 14th year, the annual eBay Auction for Power Lunch with Warren Buffett opens June 2 at 7:30pm PDT and closes Friday, June 7 at 7:30pm PDT. Last year’s winning bid set a world-record at $3,456,789.

The bidding starts at $25,000 and all bidders will be pre-qualified prior to placing their bids. To pre-qualify, please visit: The winning bidder may invite seven friends to join Buffett for lunch at Smith & Wollensky, “the quintessential New York steakhouse.” For information on the auction, visit or call 415.674.6001 or email For more information about GLIDE, visit

“As we mark 50 years in San Francisco, GLIDE is incredibly grateful to the long-term support we’ve received from Warren Buffett,” said GLIDE’s Founder and Minister of Liberation Reverend Cecil Williams. “Thanks to his vision, our ongoing partnership with eBay for 11 years, and the generosity of the winning bidders, we’ve been able to provide unconditional support to our neediest neighbors and help people regain control of their lives.”

“There's all kinds of people that need that kind of help, and I don't think anybody is better at providing it than GLIDE," said Warren Buffett.

50 years ago, Reverend Cecil Williams and Janice Mirikitani launched a movement shaped by unconditional love that changed the lives of those around them one by one. GLIDE became the heart of the city and the life force of a beloved community. In addition to serving over 800,000 meals each year, GLIDE also provides supportive housing; a nationally recognized professional nurse-based community health clinic; an educational and productive urban rooftop garden and dozens of service programs designed to help with people’s basic needs. GLIDE’s programs provide direct and compassionate benefits for thousands each year, regardless of income, gender, religion, political persuasion and any other factor.


for GLIDE Foundation

Denise Lamott, 415-381-8793

Hilton HHonors Calls on Travelers to Save with The Great Getaway

Global offerings include low hotel rates in the U.S. and discounts around the world

ME Newswire / Business Wire

MCLEAN, Va. - Thursday, May 23rd 2013

Booking a vacation just got simpler. Now through September 30, 2013, Hilton HHonors is encouraging travelers around the world to save with The Great Getaway, offering hotel rates as low as $100 in the U.S., up to 25 percent off stays in Middle East and Africa, and up to 20 percent off stays in Asia Pacific when booking within the Hilton Worldwide portfolio*. The portfolio includes Waldorf Astoria Hotels & Resorts, Conrad Hotels & Resorts, Hilton Hotels & Resorts, DoubleTree by Hilton, Embassy Suites Hotels, Hilton Garden Inn, Hampton Hotels, Homewood Suites by Hilton, Home2 Suites by Hilton and Hilton Grand Vacations.

Whether the next trip is a family affair or girls weekend in the city, The Great Getaway makes getting away easier. And, with more than 3,900 properties in 90 countries there is a vacation destination for everyone:

    Boca Raton Resort & Club, A Waldorf Astoria Resort – Designed by legendary architect Addison Mizner, Boca Raton Resort & Club, A Waldorf Astoria Resort has reigned as an icon of elegance for more than 80 years. Today, the resort remains faithful to its glamorous past, while radiating vibrant energy and offering infinite amenities to every type of guest. Experience True Waldorf Service with authentic, personalized attention that consistently meets your luxury travel needs from the moment you book your trip through the time you depart.
    Conrad Beijing – Each Conrad hotel is a reflection of its city and culture, and the newly opened Conrad Beijing is no exception. It features rooms designed with an oriental influence and floor-to-ceiling windows that offer picturesque views of Tuanjie Lake Park, the iconic CCTV building and Beijing skyline. And, to accommodate today’s luxury traveler, guests can customize details of their hotel stay before and during each visit with Conrad Concierge – the first service-enabled technology that is completely integrated with hotel management systems across the brand’s portfolio.
    Hilton Hawaiian Village® Waikiki Beach Resort – Waikiki’s only true destination resort, Hilton Hawaiian Village Waikiki Beach Resort, stands oceanfront on iconic Waikiki beach and offers a one-of-a-kind vacation atmosphere with lush tropical gardens, waterfalls and exotic wildlife throughout 22 acres of island paradise. A dynamic array of leisure options include 16 dining outlets, a "Village" destination resort concept unique among other Hawaii properties, six pools including separate pools at Ali'i Tower® and Kalia Tower®, the world-class Mandara Spa, Camp Penguin children’s program and daily activities ranging from Hula to snorkeling lessons to the Waikiki Starlight Luau.
    DoubleTree by Hilton Istanbul – Old Town – One of the hottest tourism destinations in Europe, Istanbul offers an exhilarating mix of historical and modern sights. Located on the Golden Horn peninsula of the thriving Turkish capital, this hotel is one of three Istanbul hotels from DoubleTree and is walking distance to the Grand Bazaar and near to other must-see attractions including the Topkapi Palace, Hagia Sophia and Blue Mosque – all of which provide a glimpse into the fascinating history of a city which spans two continents.
    Embassy Suites Houston – Downtown – This award winning hotel overlooks Discovery Green Park and is only steps away from the Houston Center Business District, the George R. Brown Convention Center, Houston Astros Minute Maid Park, Houston Rockets Toyota Center, the Houston Pavilions entertainment complex and the Park Shops. Making the guest experience more comfortable, guests can always enjoy the brand's three signature offerings of free-cooked-to order breakfast, two-room suites and nightly complimentary evening reception.
    Hilton Garden Inn Hotels Manhattan – From the hustle and lights of Times Square, to the chic neighborhoods of SoHo and Tribeca, to world famous shopping in Herald Square, guests of the four Hilton Garden Inn hotels in Manhattan are close to everything the Big Apple has to offer. Guests can also include a cooked-to-order breakfast, complimentary Internet access, as well as other amenities such as a complimentary onsite business center and fitness center.
    Hampton Inn Phoenix/Scottsdale @ Shea Blvd – Located in the center of Scottsdale, the Hampton Inn Phoenix/Scottsdale @ Shea Blvd is within walking distance of more than 15 golf courses, 22 restaurants, shopping areas and is surrounded by tennis courts and parks. In addition to offering several guest amenities such as free Wi-Fi and a complimentary local shuttle, the Hampton On the House® free hot breakfast, which includes fresh-baked waffles and freshly cooked oatmeal, is not to be missed.
    Homewood Suites by Hilton Orlando – Whether in Orlando for business or to visit Walt Disney World®, SeaWorld® or the Kennedy Space Center, you’re assured of the warmest Florida welcomes at this all-suite, residential-style Universal Studios Orlando hotel. Shuttle service is available to nearby theme parks, and if the kids still need entertainment families can shoot hoops on the outdoor sports court or challenge each other to a game of air hockey in the hotel’s game room.
    Home2 Suites by Hilton Baltimore Downtown, MD – Surrounded by the urban Mt. Vernon neighborhood, the cultural center of Baltimore, the Home2 Suites by Hilton Baltimore Downtown, MD is within walking distance to restaurants and bars, historic buildings, parks and art galleries. Make yourself comfortable in a modern studio or one-bedroom suite featuring moveable furniture, a living area with sofa bed, fully equipped kitchen and plenty of storage. Complimentary breakfast is served daily in the Oasis.
    Elara, a Hilton Grand Vacations Hotel – Center Strip – At the heart of the Las Vegas Strip, Elara is connected to more than 170 shops in the Miracle Mile, adjacent to Planet Hollywood Resort & Casino and just across from City Center. Luxurious studios and one-, two-, three- and four-bedroom suites capture the cosmopolitan vibe of Las Vegas while delivering the quintessential comforts of a residential retreat. Guests may soak away stress at the exotic pool and whirlpool spas or share a Great Getaway with friends by taking refuge in a private, poolside cabana.

“When you have a trip in your future, it changes your perspective. You see a hotel as more than just a bed, but an experience you’ll never forget,” said Jeff Diskin, executive vice president, Hilton Worldwide. “With only 32 weekends left in the year, the Hilton HHonors Great Getaway campaign gives travelers around the world a reason to book their dream vacation now.”

For full terms and conditions, or to book a stay, visit To become a Hilton HHonors member, visit

*Sample daily rates featured are subject to availability for travel through July 31, 2013. Rates will vary based on individual hotels and specific travel dates selected. Each hotel has a policy addressing cancellations and/or blackout dates that may apply. Unless otherwise stated, quoted rates are per room per night, based on double occupancy and do not include taxes, gratuities, incidental charges or resort fees (where applicable). Hilton HHonors™ membership, earning of Points & Miles™ and redemption of Points are subject to HHonors Terms and Conditions.

About Hilton Worldwide

Hilton Worldwide is a leading global hospitality company, spanning the lodging sector from luxurious full-service hotels and resorts to extended-stay suites and mid-priced hotels. For 93 years, Hilton Worldwide has offered business and leisure travelers the finest in accommodations, service, amenities and value. The company is dedicated to continuing its tradition of providing exceptional guest experiences across its global brands. Its brands are comprised of more than 3,900 hotels and timeshare properties, with 650,000 rooms in 90 countries and territories and include Waldorf Astoria Hotels & Resorts, Conrad Hotels & Resorts, Hilton Hotels & Resorts, DoubleTree by Hilton, Embassy Suites Hotels, Hilton Garden Inn, Hampton Hotels, Homewood Suites by Hilton, Home2 Suites by Hilton and Hilton Grand Vacations. The company also manages the world-class guest reward program Hilton HHonors®. Visit for more information and connect with Hilton Worldwide at,,, and

About Hilton HHonors

Hilton HHonors, the award-winning guest-loyalty program for Hilton Worldwide’s 10 distinct hotel brands, offers its 34 million members more ways to earn and redeem points than any other guest-loyalty program, enabling them to create experiences worth sharing at more than 3,900 hotels in 90 countries and territories. HHonors members can now redeem points for any room, anywhere, anytime, including the most luxurious suites, using any of four room rewards: Premium Room Rewards, Room Upgrade Rewards, Points & Money Rewards and Standard Room Rewards. In addition, HHonors members can use points to purchase unique experience rewards, merchandise and vacation packages, make charitable contributions and more. HHonors is also the only guest-loyalty program to offer ‘No Blackout Dates’ and ‘Points & Miles’ for the same stay at its properties worldwide, including participating Waldorf Astoria Hotels & Resorts, Conrad Hotels& Resorts, Hilton Hotels & Resorts, DoubleTree by Hilton, Embassy Suites Hotels, Hilton Garden Inn, Hampton Hotels, Homewood Suites by Hilton, Home2 Suites by Hilton and Hilton Grand Vacations. Membership in HHonors is free, and travelers may enroll online by visiting or connect with Hilton HHonors at Members can now also book reservations, manage their accounts and redeem special offers with the new Hilton HHonors mobile app for iPhone.


Dasha Ross

Hilton Worldwide


OtterBox Acquires LifeProof

FORT COLLINS, Colo. - Thursday, May 23rd 2013 [ME NewsWire]

(BUSINESS WIRE)-- OtterBox®, the global leader in protection for handheld technology, today announced the acquisition of TreeFrog Developments Inc., DBA LifeProof®. Founded in 2009 and headquartered in San Diego, LifeProof is an award-winning maker of protective cases and complementary accessories for smartphones and tablets.

Much like OtterBox, LifeProof is a rapidly growing, multi-million dollar business with a strong global brand, comprehensive product offering, impressive intellectual property and thriving company culture. Over the next 30 days, OtterBox will begin incorporating the LifeProof brand into the OtterBox family. More information about product availability and alignment will be determined at the completion of the integration.

“The joining of OtterBox and LifeProof is a way to combine two great brands and provide customers with even more great products, services and choices for smartphone accessories,” OtterBox CEO Brian Thomas said. “Both companies are successful because we foster an environment where everyone takes pride in being part of a culture that knows how to identify opportunities and grow them quickly. Our goal in this acquisition is to create more value for our customers than we ever could have generated while operating individually.”

A key driver for the acquisition is about creating customers who are passionate about the OtterBox brand. “Our strategy is to utilize our combined brand momentum, and world-class talent to create a great customer experience that generates OtterBox brand ambassadors for life,” Thomas said. “Our customers and our employees are the ones who have the passion for the brand that allows us to succeed. This passionate spirit motivates us to build better teams, better companies and ultimately, better communities. At the end of the day, that is our goal.”

OtterBox employs approximately 650 people worldwide. LifeProof employed approximately 250 people, who are now members of the OtterBox family and will remain in their San Diego location for the foreseeable future.

OtterBox has been a family-owned business since 1998. The financial details and terms of the agreement are confidential.

About LifeProof:

Based in San Diego, LifeProof designs, manufactures and markets cases for smartphones and tablets that deliver protection, style and functionality. LifeProof is built on the idea of giving everyone the complete freedom and confidence to use their mobile devices in any environment. Designed to defend against water, dirt, snow, shock and the hazards of daily life, LifeProof lets consumers use their mobile device every day, everywhere, and for everything, without worry.

For more information, visit

About OtterBox:

Founded in 1998, OtterBox creates premium technology accessories for smartphones, tablets and mobile devices. The top mobile device manufacturers, big box retailers and wireless services providers in the world value their partnership with OtterBox to increase device sales and to strengthen their own brand equity. OtterBox works endlessly to create a strong connection with consumers through first-class customer service, commitment to premium product quality and constant voice-of-the-consumer efforts.

OtterBox has been a five-time honoree on the Inc. 500 list of fastest growing private companies in the US, recognized in the Top 10 by the Forbes Magazine America’s Most Promising Companies list and is a repeat honoree in the Great Place to Work annual survey published by FORTUNE Magazine. The multi-million dollar company has global headquarters in Fort Collins, Colo. and offices in Boston, San Diego, Cork, Ireland and Hong Kong.

OtterBox is the No. 1-selling case for smartphones* and offers an extensive lineup of screen protectors, cases and other accessories that enhance various consumer lifestyles.

For more information, visit We’ve Got Technology Covered.


*Source: The NPD Group/Retail Tracking Service/November 2010-December 2012

©2013 Otter Products, LLC. All rights reserved. OtterBox and all OtterBox logos, trademarks and symbols are the property of Otter Products, LLC. All other logos, trademarks and symbols are the property of their respective owners.



Kelly Richardson, 970-372-1875

Thursday, May 23, 2013

Wireless Seismic Announces Sale of RT System 2 to West Bay Geophysical

RT System 2 – A RealTIME and CableFREE seismic data acquisition system scalable to high channel count configurations

SUGAR LAND, Texas - Thursday, May 23rd 2013 [ME NewsWire]

(BUSINESS WIRE)-- Wireless Seismic, Inc., the leading innovator of real-time and cable-free seismic data acquisition systems for the oil and gas industry, announced today the sale of its RT System 2 seismic data acquisition system to West Bay Geophysical, Inc., a subsidiary of West Bay Exploration. Headquartered in Traverse City, Michigan, West Bay will use the RT System 2 for 2D and 3D vibroseis projects in Michigan starting in early July.

“A key factor in selecting the RT System 2 for our acquisition operations is its environmental friendliness, particularly in the sensitive terrains in which we work,” stated Jim Bowser, General Manager, West Bay Geophysical. “With the minimal amount of equipment and rapid deployment, we are able to substantially reduce the complexity of acquiring permitting licenses, as well as decreasing permitting fees.”

“Another important feature of the RT System 2 is the ability to QC the data as it is being acquired, just as with any cabled system, but without the constraints of cables,” added Bowser. “It would be very challenging for us to achieve our high standard of data quality with any other cable-free system.”

“West Bay sees the deployment of RT System 2 as a way to reduce costs and environmental impact while increasing operational efficiency,” added Roy Kligfield, CEO of Wireless Seismic. “We look forward to working with West Bay’s personnel to ensure that these benefits are realized.”

About West Bay Exploration

West Bay Exploration Company, based in Traverse City, Michigan, uses the latest geological, geophysical, and environmental technology to locate, drill, and produce hydrocarbons from reserves in the continental United States. West Bay provides land and mineral owners the opportunity to maximize the development of their petroleum resources in ways that are environmentally safe and effective.

About Wireless Seismic

Wireless Seismic, Inc. is revolutionizing onshore seismic data acquisition with RT System 2, the industry’s only fully scalable wireless seismic recording system with real-time data transmission. Headquartered in Sugar Land, Texas, with offices worldwide, the company’s recording systems enable contractors to efficiently tackle the most challenging projects by delivering commercially compelling solutions for conventional surveys and passive monitoring for hydraulic fracturing.


Wireless Seismic

Patricia Jonesi, 832-532-5012